Crossmark

Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial

Crossref DOI link: https://doi.org/10.1186/s12917-018-1423-2

Published Online: 2018-03-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Richbourg, Heather A.

Mitchell, Colin F.

Gillett, Ashley N.

McNulty, Margaret A.
Funding

Funding for this research was provided by:

EHSP/Cusimano Grant (166080121-2636 (2015))

EHSP/Cusimano (166080121-2636 (2016))
License Information

Text and Data Mining valid from 2018-03-20
More Information

Article History

Received: 20 July 2017

Accepted: 13 March 2018

First Online: 20 March 2018

Ethics approval and consent to participate

: This study was approved by Louisiana State University School of Veterinary Medicine Institutional Animal Care and Use Committee (Protocol #14–069 and #15–081).

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.